Gallagher WM - Search Results

1

Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM. Duffy MJ, et al. Among authors: gallagher wm. Cancer Lett. 2007 Apr 28;249(1):49-60. doi: 10.1016/j.canlet.2006.12.020. Epub 2007 Feb 1. Cancer Lett. 2007. PMID: 17275177 Review.

2

Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissues.

Gallagher WM, Greene LM, Ryan MP, Sierra V, Berger A, Laurent-Puig P, Conseiller E. Gallagher WM, et al. FEBS Lett. 2001 Jan 26;489(1):59-66. doi: 10.1016/s0014-5793(00)02389-9. FEBS Lett. 2001. PMID: 11231014

3

Elevated expression and altered processing of fibulin-1 protein in human breast cancer.

Greene LM, Twal WO, Duffy MJ, McDermott EW, Hill AD, O'Higgins NJ, McCann AH, Dervan PA, Argraves WS, Gallagher WM. Greene LM, et al. Among authors: gallagher wm. Br J Cancer. 2003 Mar 24;88(6):871-8. doi: 10.1038/sj.bjc.6600802. Br J Cancer. 2003. PMID: 12644824 Free PMC article.

4

A potent nonporphyrin class of photodynamic therapeutic agent: cellular localisation, cytotoxic potential and influence of hypoxia.

Gallagher WM, Allen LT, O'Shea C, Kenna T, Hall M, Gorman A, Killoran J, O'Shea DF. Gallagher WM, et al. Br J Cancer. 2005 May 9;92(9):1702-10. doi: 10.1038/sj.bjc.6602527. Br J Cancer. 2005. PMID: 15841085 Free PMC article.

5

Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.

Gallagher WM, Bergin OE, Rafferty M, Kelly ZD, Nolan IM, Fox EJ, Culhane AC, McArdle L, Fraga MF, Hughes L, Currid CA, O'Mahony F, Byrne A, Murphy AA, Moss C, McDonnell S, Stallings RL, Plumb JA, Esteller M, Brown R, Dervan PA, Easty DJ. Gallagher WM, et al. Carcinogenesis. 2005 Nov;26(11):1856-67. doi: 10.1093/carcin/bgi152. Epub 2005 Jun 15. Carcinogenesis. 2005. PMID: 15958521

6

Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response.

Brennan DJ, O'Brien SL, Fagan A, Culhane AC, Higgins DG, Duffy MJ, Gallagher WM. Brennan DJ, et al. Among authors: gallagher wm. Expert Opin Biol Ther. 2005 Aug;5(8):1069-83. doi: 10.1517/14712598.5.8.1069. Expert Opin Biol Ther. 2005. PMID: 16050784 Review.

7

Proteomic analysis of factors released from p21-overexpressing tumour cells.

Currid CA, O'Connor DP, Chang BD, Gebus C, Harris N, Dawson KA, Dunn MJ, Pennington SR, Roninson IB, Gallagher WM. Currid CA, et al. Among authors: gallagher wm. Proteomics. 2006 Jul;6(13):3739-53. doi: 10.1002/pmic.200500787. Proteomics. 2006. PMID: 16739131

8

Protein tyrosine phosphatases, new targets for cancer therapy.

Easty D, Gallagher W, Bennett DC. Easty D, et al. Curr Cancer Drug Targets. 2006 Sep;6(6):519-32. doi: 10.2174/156800906778194603. Curr Cancer Drug Targets. 2006. PMID: 17017875 Review.

9

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

Brennan DJ, Jirstrom K, Kronblad A, Millikan RC, Landberg G, Duffy MJ, Rydén L, Gallagher WM, O'Brien SL. Brennan DJ, et al. Among authors: gallagher wm. Clin Cancer Res. 2006 Nov 1;12(21):6421-31. doi: 10.1158/1078-0432.CCR-06-0480. Clin Cancer Res. 2006. PMID: 17085655 Clinical Trial.

10

CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

O'Brien SL, Fagan A, Fox EJ, Millikan RC, Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, Higgins DG, Jirström K, Landberg G, Gallagher WM. O'Brien SL, et al. Among authors: gallagher wm. Int J Cancer. 2007 Apr 1;120(7):1434-43. doi: 10.1002/ijc.22413. Int J Cancer. 2007. PMID: 17205517 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results